Current risk stratification algorithms capture high-risk individuals with classical risk factors or established atherosclerotic cardiovascular disease (ASCVD). However, a clinically relevant proportion of individuals without threshold levels of standard modifiable risk factors (SMuRF) – namely hypertension, dysli...
F. Kahles, B. Kurt, K. Schneider et al.· European Heart Journal· 0 citations
High-sensitivity C-reactive protein (hsCRP) is the guideline-recommended biomarker for assessment of residual inflammatory risk in atherosclerotic cardiovascular disease (ASCVD). Clinical adoption remains limited, especially in individuals without established ASCVD. This study used longitudinal measurements to ev...
B. Kurt, M. Reugels, K. Schneider et al.· European Heart Journal· 0 citations
Traditional risk factors for atherosclerotic cardiovascular disease (ASCVD) fail to fully reflect the residual risk, driven by chronic low-grade inflammation, observed in many. Generally, high-sensitivity C-reactive protein (hsCRP) concentrations remain stable, but some individuals may experience increases. More...
F. Kahles, M. Reugels, K. Schneider et al.· European Heart Journal· 0 citations
Cardiovascular (CV) inflammation, defined as high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, is often present in individuals with atherosclerotic cardiovascular disease (ASCVD) with or without chronic kidney disease (CKD). However, there are limited data regarding disparities in the prevalence of CV inflamma...
G. Liuzzo, J. Amerena, S. Genth-Zotz et al.· European Heart Journal· 0 citations
Low-grade chronic inflammation is increasingly recognized as a key contributor to cardiovascular disease, yet its incremental value in risk stratification beyond established clinical scores remains uncertain.
To evaluate the association between inflammatory biomarkers and cardiovascular risk factors, and t...
A. d'Aiello, F. Jiménez-Trinidad, A. Severino et al.· European Heart Journal· 0 citations
The observed HF-cancer association is influenced by statistical methodology, shared risk factors, differences in surveillance intensity and cancer type, that confound analyses investigating possible causal biological links.
L. Sanasi, A. Iaconelli, Danila Azzolina et al.· European Journal of Heart Fa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.